Cost-effectiveness analysis of apixaban compared with other oral anticoagulants for the treatment of non-valvular atrial fibrillation in a Belgian healthcare setting

Development of Cardiovascular Risk Equations in People with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes Based on the SELECT Trial

Composite endpoints in health technology assessment: Part 1 – an illustration of best modeling practice

Composite endpoints in health technology assessment: Part 2 – expanding the evidence base with a framework for best modeling practice

Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes

The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis

Best-Practice Biomarker Testing of Oesophago-Gastric Cancer in the UK: Expert Consensus Recommendations Developed Using a Modified Delphi

The Broader Effects of Delayed Progression to End-Stage Kidney Disease: Delaying the Inevitable or a Meaningful Change?

Cost offset of dapagliflozin in the US Medicare population with cardio-kidney metabolic syndrome

Hyperkalemia in chronic kidney disease patients with and without heart failure: an Italian economic modelling study